i
Loading Page
loading, please wait

Select Year:

Home > IL Providers
provider's profile picture

Dr. Richard Gerald Harris, MD, FACS

(No ratings)

Specializes in: Urologic Oncology
Rosalind Franklin University of Medicine and Science, Chicago Medical School (1980)
Professional interests include: benign prostatic hyperplasia (enlarged prostate), cryosurgery, prostate problems, and more.
501 W North Avenue Suite 201
Melrose Park, IL 60160

Dr. Richard Gerald Harris, MD, FACS is an urologic oncologist in Melrose Park, IL specializing in urologic oncology. He graduated from Rosalind Franklin University of Medicine and Science, Chicago Medical School in 1980 and has 46 years of experience. Dr. Richard Gerald Harris, MD, FACS is affiliated with UroPartners.

View Doctor's Full Profile (708) 450-5055

Office Locations

501 W North Avenue Suite 201
Melrose Park, IL 60160
open_in_new

Some issues Dr. Richard Gerald Harris, MD, FACS can help you with:

Benign Prostatic Hyperplasia (Enlarged Prostate)

Benign prostatic hyperplasia (BPH) is a noncancerous condition in which the prostate gland becomes enlarged. BPH affects about half of men between the ages of 50 and 60, and approximately 80% of men over 80. As the prostate grows in size, it can press down on the tube where urine flows out of the body (the urethra) and cause urinary problems.

Medication can relieve mild to moderate symptoms of BPH, such as frequent urination, incomplete bladder emptying, a weak urine stream, and straining while urinating. However, other forms of treatment may be more appropriate if an individual has pain with urination, frequent urinary tract infections, or is unable to urinate. The size of the prostate and the severity of their symptoms will determine the type of treatment they need. If the prostate is not very large, doctors will likely recommend a transurethral procedure. This minimally invasive technique involves the insertion of a scope into the urethra. The most common transurethral procedures for BPH are:

  • Transurethral incision of the prostate or TUIP, where the surgeon uses the scope to make small cuts in the area of the prostate that meets the bladder. These cuts will open up the pathway for urine and allow it to flow with more ease.
  • Transurethral needle ablation or TUNA, where needles are inserted through the scope and into the prostate. The needles use radiofrequency waves to destroy excess prostate tissue.
  • Laser prostate ablation, where lasers pass through the scope to melt away the part of the prostate causing urine blockage.
  • Transurethral resection of the prostate or TURP, where the inside of the prostate is trimmed and removed one tiny piece at a time using the scope.

If the prostate is too big for a transurethral procedure, an individual may need a simple prostatectomy, which can be done in one of three ways: laparoscopic, robotic, or open. During a laparoscopic simple prostatectomy, a surgeon makes several small incisions on the belly. Then they insert a long tube with a camera into one of the cuts and surgical instruments into the others. Using the camera to see inside the belly, they carefully removes the enlarged part of the prostate. Robotic simple prostatectomy uses the same techniques as the laparoscopic method, but the surgery is done with the help of a robot. For men with very large prostates, open simple prostatectomy may be the best treatment option. This surgery differs from the other approaches in that it requires a much larger incision.

Most transurethral treatments for BPH, like TUIP, TUNA, and laser prostate ablation, are done in the doctor's office or outpatient surgery center. TURP and simple prostatectomy, however, need to be performed in the hospital and require an average stay of one to three days. Patients should wait a week before doing any strenuous activities after a TUIP, TUNA, or laser prostate ablation, and about four to six weeks after a TURP or simple prostatectomy. Although these treatments improve BPH symptoms for most patients, it is important to be aware of the risks involved, such as urine control issues, tightening of the urethra, and erectile dysfunction.

In The News 

“NPR's Richard Harris went to the American Society of Clinical Oncology meeting in Chicago and found oncologists focusing less on the newest treatments, and more on all the therapies that aren't...”—"Alex Azar faces House committee to discuss HHS policies, strategy", Politico, June 2018

Noteworthy Medicare Patient Procedures Performed by Dr. Richard Gerald Harris, MD, FACS in 2023

Click on any procedure below to see further details on volume and pricing among Medicare patients.

Top 5%

By Volume:

chronic care

By Affordability:

blood draw
blood draw for lab tests
phlebotomy for lab tests
prostate-specific antigen test
total PSA test
venipuncture

In 2023, among providers in related specialties within Illinois, Dr. Richard Gerald Harris, MD, FACS performed more chronic care procedures for Medicare patients than 95% of them and he also had a list price for blood draw, blood draw for lab tests, phlebotomy for lab tests, prostate-specific antigen (PSA) test, total PSA test, and venipuncture (phlebotomy) that was lower than the list prices billed to Medicare by 95% of them. Actual amounts paid by patients can vary widely depending on a number of factors, including insurance coverage. A lower list price, however, might mean lower fees when paying without insurance.

Top 25%

By Volume:

blood draw
phlebotomy for lab tests
urinalysis

In 2012, Dr. Richard Gerald Harris, MD, FACS performed more blood draw, phlebotomy for lab tests, and urinalysis procedures for Medicare patients than 75% of providers in related specialties within Illinois.

Medicare Procedure and Patient Information

2012 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2012 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 522
catheterization 51
diagnostic procedures 52
doctor visit 1632
foreign body removal 12
hormone therapy 92
hospital care 44
inpatient care 44
lab tests 2130
minimally invasive procedures 248
minor procedures 52
stent placement (stenting) 14
urologic procedures 972

Medicare Procedure and Patient Information

2013 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2013 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

ablation 19
blood draw 574
catheterization 58
cryotherapy 19
diagnostic procedures 44
doctor visit 1584
hormone therapy 56
hospital care 52
inpatient care 52
lab tests 2048
laser treatment 19
minimally invasive procedures 209
minor procedures 44
urologic procedures 911

2013 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Gender
Male 683
Female 74
Ethnicity
Non-Hispanic White 491
Black 155
Hispanic 87
Asian 0
Other 0
Native American 0
Age
From 65 to 74 322
From 75 to 84 274
85 and over 123
Less than 65 38

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2013

Hypertension 71
High Cholesterol 60
Stroke 5
Ischemic Heart Disease 44
Depression 10
Chronic Kidney Disease 23
Asthma 4
Osteoperosis 4
Atrial Fibrilation 10
Heart Failure 16
Chronic Obstructive Pulmonary Disease 11
Diabetes 38
Dementia 11
Cancer 40

Medicare Procedure and Patient Information

2014 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2014 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 506
catheterization 62
diagnostic procedures 31
doctor visit 1402
hormone therapy 45
hospital care 55
inpatient care 55
lab tests 1813
minimally invasive procedures 161
minor procedures 31
urologic procedures 778

2014 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Gender
Male 644
Female 70
Ethnicity
Non-Hispanic White 464
Black 138
Hispanic 97
Asian 0
Other 0
Native American 0
Age
From 65 to 74 292
From 75 to 84 261
85 and over 123
Less than 65 38

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2014

Hypertension 71
High Cholesterol 60
Stroke 6
Ischemic Heart Disease 45
Depression 11
Chronic Kidney Disease 25
Asthma 4
Osteoperosis 4
Atrial Fibrilation 12
Heart Failure 19
Chronic Obstructive Pulmonary Disease 12
Diabetes 37
Dementia 10
Cancer 39

Medicare Procedure and Patient Information

2015 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2015 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 439
catheterization 46
diagnostic procedures 44
doctor visit 1288
hormone therapy 46
hospital care 53
inpatient care 53
lab tests 1638
minimally invasive procedures 139
minor procedures 44
urologic procedures 658

2015 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Gender
Male 1254
Female 80
Ethnicity
Non-Hispanic White 880
Black 222
Hispanic 190
Asian 0
Other 0
Native American 0
Age
From 65 to 74 564
From 75 to 84 504
85 and over 222
Less than 65 44

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2015

Hypertension 69
High Cholesterol 62
Stroke 6
Ischemic Heart Disease 48
Depression 11
Chronic Kidney Disease 27
Asthma 8
Osteoperosis 3
Atrial Fibrilation 14
Heart Failure 18
Chronic Obstructive Pulmonary Disease 13
Diabetes 37
Dementia 11
Cancer 38

Medicare Procedure and Patient Information

2016 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2016 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 422
diagnostic procedures 37
doctor visit 1149
hormone therapy 41
hospital care 29
inpatient care 29
lab tests 1523
minimally invasive procedures 133
minor procedures 37
urologic procedures 555

2016 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Gender
Male 541
Female 31
Ethnicity
Non-Hispanic White 374
Black 101
Hispanic 79
Asian 0
Other 0
Native American 0
Age
From 65 to 74 226
From 75 to 84 225
85 and over 89
Less than 65 32

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2016

Hypertension 71
High Cholesterol 63
Stroke 4
Ischemic Heart Disease 45
Depression 10
Chronic Kidney Disease 32
Asthma 13
Osteoperosis 4
Atrial Fibrilation 11
Heart Failure 17
Chronic Obstructive Pulmonary Disease 12
Diabetes 37
Dementia 10
Cancer 42

Medicare Procedure and Patient Information

2017 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2017 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

ablation 12
blood draw 382
diagnostic procedures 27
doctor visit 987
hormone therapy 52
lab tests 1346
minimally invasive procedures 144
minor procedures 27
urologic procedures 535

2017 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Gender
Male 502
Female 33
Ethnicity
Non-Hispanic White 356
Black 91
Hispanic 68
Asian 0
Other 0
Native American 0
Age
From 65 to 74 204
From 75 to 84 205
85 and over 100
Less than 65 26

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2017

Hypertension 72
High Cholesterol 51
Stroke 3
Ischemic Heart Disease 43
Depression 10
Chronic Kidney Disease 31
Asthma 3
Osteoperosis 3
Atrial Fibrilation 12
Heart Failure 19
Chronic Obstructive Pulmonary Disease 13
Diabetes 34
Dementia 10
Cancer 41

Medicare Procedure and Patient Information

2018 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2018 were lab tests, urologic procedures, blood draw and minimally invasive procedures.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 351
catheterization 25
diagnostic procedures 16
doctor visit 859
hormone therapy 56
hospital care 12
inpatient care 12
lab tests 1117
minimally invasive procedures 86
minor procedures 16
urologic procedures 401

2018 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Gender
Male 478
Female 30
Ethnicity
Non-Hispanic White 323
Black 91
Hispanic 75
Asian 0
Other 0
Native American 0
Age
From 65 to 74 197
From 75 to 84 203
85 and over 81
Less than 65 27

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2018

Hypertension 74
High Cholesterol 62
Stroke 3
Ischemic Heart Disease 40
Depression 13
Chronic Kidney Disease 34
Asthma 4
Osteoperosis 2
Atrial Fibrilation 10
Heart Failure 18
Chronic Obstructive Pulmonary Disease 11
Diabetes 36
Dementia 8
Cancer 40

Medicare Procedure and Patient Information

2019 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2019 were lab tests, blood draw, urologic procedures and minimally invasive procedures.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 340
diagnostic procedures 13
doctor visit 696
hormone therapy 56
lab tests 936
minimally invasive procedures 73
minor procedures 13
urologic procedures 270

2019 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Gender
Male 390
Female 11
Ethnicity
Non-Hispanic White 269
Black 72
Hispanic 43
Asian 0
Other 0
Native American 0
Age
From 65 to 74 149
From 75 to 84 175
85 and over 0
Less than 65 0

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2019

Hypertension 75
High Cholesterol 63
Stroke 0
Ischemic Heart Disease 39
Depression 9
Chronic Kidney Disease 33
Asthma 3
Osteoperosis 3
Atrial Fibrilation 12
Heart Failure 19
Chronic Obstructive Pulmonary Disease 11
Diabetes 36
Dementia 8
Cancer 44

Medicare Procedure and Patient Information

2020 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2020 were lab tests, blood draw, urologic procedures and hormone therapy.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 198
doctor visit 313
hormone therapy 27
lab tests 414
minimally invasive procedures 27
urologic procedures 85

2020 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Ethnicity
Non-Hispanic White 187
Black 44
Hispanic 33
Asian 0
Other 0
Native American 0
Age
From 65 to 74 118
From 75 to 84 115
85 and over 0
Less than 65 0

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2020

Hypertension 69
High Cholesterol 60
Stroke 4
Ischemic Heart Disease 33
Depression 6
Chronic Kidney Disease 34
Asthma 0
Osteoperosis 0
Atrial Fibrilation 11
Heart Failure 17
Chronic Obstructive Pulmonary Disease 11
Diabetes 33
Dementia 5
Cancer 48

Medicare Procedure and Patient Information

2021 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2021 were lab tests, blood draw, urologic procedures and hormone therapy.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 223
doctor visit 382
hormone therapy 33
lab tests 517
minimally invasive procedures 28
urologic procedures 85

2021 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Ethnicity
Non-Hispanic White 161
Black 53
Hispanic 30
Asian 0
Other 0
Native American 0
Age
From 65 to 74 93
From 75 to 84 111
85 and over 0
Less than 65 0

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2021

Hypertension 75
High Cholesterol 64
Stroke 0
Ischemic Heart Disease 36
Depression 6
Chronic Kidney Disease 38
Asthma 0
Osteoperosis 5
Atrial Fibrilation 12
Heart Failure 18
Chronic Obstructive Pulmonary Disease 9
Diabetes 33
Dementia 6
Cancer 46

Medicare Procedure and Patient Information

2022 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2022 were lab tests, blood draw, chronic care and urologic procedures.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 144
chronic care 71
doctor visit 294
hormone therapy 32
lab tests 363
minimally invasive procedures 22
urologic procedures 63

2022 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Ethnicity
Non-Hispanic White 139
Black 42
Hispanic 23
Asian 0
Other 0
Native American 0
Age
From 65 to 74 83
From 75 to 84 92
85 and over 0
Less than 65 0

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2022

Hypertension 75
High Cholesterol 75
Stroke 6
Ischemic Heart Disease 32
Depression 6
Chronic Kidney Disease 23
Asthma 0
Osteoperosis 7
Atrial Fibrilation 18
Heart Failure 12
Chronic Obstructive Pulmonary Disease 10
Diabetes 37
Dementia 6
Cancer 54

Medicare Procedure and Patient Information

2023 Medicare Procedure Volume

The top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL during 2023 were lab tests, blood draw, urologic procedures and chronic care.

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

blood draw 108
chronic care 53
doctor visit 221
hormone therapy 31
lab tests 275
minimally invasive procedures 16
urologic procedures 59

2023 Medicare Patient Data

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Gender
Male 167
Female 0
Ethnicity
Non-Hispanic White 102
Black 38
Hispanic 0
Asian 0
Other 0
Native American 0
Age
From 65 to 74 58
From 75 to 84 73
85 and over 0
Less than 65 0

Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS in 2023

Hypertension 75
High Cholesterol 75
Stroke 7
Ischemic Heart Disease 30
Depression 7
Chronic Kidney Disease 21
Asthma 0
Osteoperosis 0
Atrial Fibrilation 20
Heart Failure 15
Chronic Obstructive Pulmonary Disease 8
Diabetes 37
Dementia 0
Cancer 49

Medicare Procedure and Patient Information

Average Medicare Procedure Volume From 2012 - 2023

Volume of procedures performed by Dr. Richard Gerald Harris, MD, FACS for Medicare patients.

The highest averages for the top procedures that Dr. Richard Gerald Harris, MD, FACS treated as an urologic oncologist in Melrose Park, IL were lab tests, urologic procedures, blood draw and minimally invasive procedures.

ablation 15
blood draw 350
catheterization 48
chronic care 62
cryotherapy 19
diagnostic procedures 33
doctor visit 900
foreign body removal 12
hormone therapy 47
hospital care 40
inpatient care 40
lab tests 1176
laser treatment 19
minimally invasive procedures 107
minor procedures 33
stent placement (stenting) 14
urologic procedures 447

Average Medicare Patient Data From 2012 - 2023

Information about Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS.

Gender
Male 388
Female 27
Ethnicity
Black / African American 87
Asian / Pacific Islander 0
Non-Hispanic White 312
Hispanic 60
Native American / Alaskan Native 0
Other 0
Age
75 to 84 186
85 and over 61
Less than 65 17
65 to 74 192

Average of Total of Conditions of Medicare patients treated by Dr. Richard Gerald Harris, MD, FACS From 2012 - 2023

The highest averages of the most common conditions of Medicare patients that Dr. Richard Gerald Harris, MD, FACS treated were hypertension, high cholesterol, cancer and ischemic heart disease.

Hypertension 66
High Cholesterol 57
Stroke 3
Ischemic Heart Disease 36
Depression 8
Chronic Kidney Disease 26
Asthma 3
Osteoporosis 2
Heart Failure 15
Chronic Obstructive Pulmonary Disease 10
Diabetes 32
Atrial Fibrillation 11
Cancer 40
Dementia 7

Education & Training

Dr. Richard Gerald Harris, MD, FACS graduated from Rosalind Franklin University of Medicine and Science, Chicago Medical School in 1980. He completed residency at Loyola University Affiliated Hospitals. He is certified by the American Board of Urology and has a state license in Illinois.

Medical School: Rosalind Franklin University of Medicine and Science, Chicago Medical School (1980)

Residency: Loyola University Affiliated Hospitals (1985)

Board Certification: American Board of Urology

Licensed In: Illinois

Affiliations & Hospitals

Dr. Richard Gerald Harris, MD, FACS is associated with these hospitals and organizations:

UroPartners

Ratings & Reviews

Dr. Richard Gerald Harris, MD, FACS does not have any reviews yet, be the first to leave a review of Dr. Richard Gerald Harris, MD, FACS here: Leave a Review

(No ratings)

Leave a Review

General Payments

These charts describe general payments received by Dr. Richard Gerald Harris, MD, FACS. Doctors may receive payments for a number of reasons, including meal compensation, travel compensation, and consulting.

Payments by Company
Astellas Pharma US Inc $194,662 XTANDI
$186,873 		Enzalutamide
$5,331 		Myrbetriq
$476 		Vesicare
$401
$1,580
Janssen Biotech, Inc. $123,712 Erleada
$106,155 		AKEEGA
$6,281 		ZYTIGA
$5,211 		XARELTO
$23
$6,043
UroGPO LLC $88,574
$88,574
Valeant Pharmaceuticals North America LLC $79,872 PROVENGE
$79,872
Bayer HealthCare Pharmaceuticals Inc. $77,304 Xofigo
$53,261 		Nubeqa
$21,602 		Non-Covered
$2,441
Other $357,199 XTANDI
$64,845 		PROVENGE
$42,362 		ORGOVYX
$42,320 		Erleada
$37,667 		PYLARIFY
$11,181 		Other
$158,825
Types of Payments
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $397,109
Consulting Fee $213,182
Travel and Lodging $132,507
Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $54,900
Current or prospective ownership or investment interest $43,216
Other $80,409

Research Payments

Dr. Richard Gerald Harris, MD, FACS has received 115 research payments totaling $500,592.

Ownership and Interest Payments

This table describes ownership payments received by Dr. Richard Gerald Harris, MD, FACS.

UroGPO LLC 2020 $3,482,423.93 Physician Covered Recipient Common Stock
UroGPO LLC 2017 $3,278,421.50 Physician Covered Recipient Common Stock
SN Holdings, LLC 2023 $3,029,706.79 Physician Covered Recipient Common Stock
UroGPO LLC 2019 $1,522,112.28 Physician Covered Recipient Common Stock
SN Holdings, LLC 2022 $1,462,617.07 Physician Covered Recipient Common Stock
UroGPO LLC 2018 $1,397,456.39 Physician Covered Recipient Common Stock
SN Holdings, LLC 2021 $1,358,144.42 Physician Covered Recipient Common Stock
Great Lakes Medical Services, LLC 2019 $17,000.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
SN Holdings, LLC 2024 $14,882.63 Physician Covered Recipient Common Stock
Great Lakes Medical Services, LLC 2018 $14,000.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
Great Lakes Medical Services, LLC 2013 $11,900.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
Great Lakes Medical Services, LLC 2017 $11,000.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
Great Lakes Medical Services, LLC 2015 $10,000.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
Great Lakes Medical Services, LLC 2014 $9,000.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
Great Lakes Medical Services, LLC 2016 $9,000.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
Great Lakes Medical Services, LLC 2020 $8,000.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
SN Holdings, LLC 2024 $7,876.95 Physician Covered Recipient Common Stock
Great Lakes Medical Services, LLC 2021 $3,500.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
Great Lakes Medical Services, LLC 2023 $3,000.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest
Great Lakes Medical Services, LLC 2022 $2,700.00 Physician Covered Recipient Membership Units in Limited Liability Company-Ownership Interest

Biography

Dr. Richard Harris, who practices in Melrose Park, IL, is a medical specialist in urologic oncology. In his practice, he is particularly interested in benign prostatic hyperplasia (enlarged prostate), erectile dysfunction (impotence), and cryosurgery. He most likely takes Galaxy Health Network, Blue Cross and Blue Shield of Michigan, and Blue California, as well as other insurance carriers. Dr. Harris graduated from Rosalind Franklin University of Medicine and Science, Chicago Medical School. His residency was performed at a hospital affiliated with Loyola University. Dr. Harris is affiliated with UroPartners and Loyola Medicine. According to Loyola Medicine, new patients are welcome to contact his office in.

Other Providers in Melrose Park, IL